HERBERT, A. A.; GLAAB, D.; SCHREIBER, R. A Multicenter, Open Label, Phase 1 Study of the Safety, Tolerability, Systemic Exposure, Pharmacodynamics, and Treatment Effect of Calcipotriene Foam, 0.005% in Pediatric Subjects (Ages 2 to 11 Years) with Plaque Psoriasis. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 4, n. 5, p. s35, 2020. DOI: 10.25251/skin.4.supp.35. Disponível em: https://www.jofskin.org/index.php/skin/article/view/984. Acesso em: 30 jun. 2022.